What NEUROCRINE BIOSCIENCES INC's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 15 | 49 |
| Total trades | 44 | 210 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 76,204 | 791,025 |
| Disposed | 52,695 | 675,671 |
| Net activity | +23,509 | +115,354 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Morrow George J | Director | Nov 03 | Open-market sale · S | −1,300 | $168.53 | −$219K | 10,386 |
| Morrow George J | Director | Nov 03 | Open-market sale · S | −1,500 | $167.72 | −$252K | 11,686 |
| Morrow George J | Director | Nov 03 | Open-market sale · S | −1,466 | $166.77 | −$244K | 13,186 |
| Morrow George J | Director | Nov 03 | Open-market sale · S | −908 | $165.71 | −$150K | 14,652 |
| Morrow George J | Director | Nov 03 | Open-market sale · S | −1,226 | $164.74 | −$202K | 15,560 |
| Morrow George J | Director | Nov 03 | Open-market sale · S | −600 | $163.71 | −$98.2K | 16,786 |
| Morrow George J | Director | Nov 03 | Open-market sale · S | −100 | $162.05 | −$16.2K | 17,386 |
| Morrow George J | Director | Nov 03 | Open-market sale · S | −100 | $158.18 | −$15.8K | 17,486 |
| Morrow George J | Director | Nov 03 | Exercise / conversion · M | +7,200 | $53.64 | +$386K | 17,586 |
| Morrow George J | Director | Nov 02 | Open-market sale · S | −1,300 | $146.76 | −$191K | 10,386 |
| Morrow George J | Director | Nov 02 | Open-market sale · S | −4,300 | $145.86 | −$627K | 11,686 |
| Morrow George J | Director | Nov 02 | Open-market sale · S | −1,900 | $144.98 | −$275K | 15,986 |
| Morrow George J | Director | Nov 02 | Exercise / conversion · M | +7,500 | $53.64 | +$402K | 17,886 |
| Gano Kyle | Chief Executive Officer | Nov 01 | Withheld — tax / exercise cost · F | −332 | $146.10 | −$48.5K | 155,010 |
| Gano Kyle | Chief Executive Officer | Nov 01 | Exercise / conversion · M | +614 | — | — | 155,342 |
| Morrow George J | Director | Oct 30 | Open-market sale · S | −300 | $149.00 | −$44.7K | 10,386 |
| Morrow George J | Director | Oct 30 | Exercise / conversion · M | +300 | $53.64 | +$16.1K | 10,686 |
| Abernethy Matt | Chief Financial Officer | Sep 14 | Open-market sale · S | −2,311 | $157.20 | −$363K | 42,808 |
| Boyer David W. | Chief Corp. Affairs Officer | Sep 14 | Open-market sale · S | −826 | $157.45 | −$130K | 8,722 |
| Gorman Kevin Charles | Director | Sep 11 | Withheld — tax / exercise cost · F | −7,839 | $156.22 | −$1.22M | 517,797 |
Loading...